SymBio Pharmaceuticals Limited
Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.
4582 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区虎ノ門四丁目１番２８号
- Website:
- https://www.symbiopharma.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SymBio Pharmaceuticals Limited is a specialty pharmaceutical company dedicated to addressing unmet medical needs. Its core business model involves acquiring the rights to develop and commercialize promising new drug candidates from global bio-ventures and pharmaceutical firms. The company focuses on therapeutic areas including oncology, hematology, autoimmune diseases, and infectious diseases. SymBio aims to deliver innovative treatments to patients, particularly for conditions underserved by the broader industry, with a primary market focus on Japan and the Asia-Pacific region.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SymBio Pharmaceuticals Limited and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-05 02:11 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2025-08-04 09:05 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 281.2 KB | |
| 2025-08-04 09:04 |
Interim Report
半期報告書－第21期(2025/01/01－2025/12/31)
|
Japanese | 356.9 KB | |
| 2025-07-31 08:37 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 276.5 KB | |
| 2025-07-22 09:24 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 524.8 KB | |
| 2025-04-21 03:23 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 36.1 KB | |
| 2025-04-18 09:38 |
Share Issue/Capital Change
訂正臨時報告書
|
Japanese | 40.4 KB | |
| 2025-03-26 05:29 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 207.2 KB | |
| 2025-03-26 05:04 |
Regulatory News Service
臨時報告書
|
Japanese | 26.2 KB | |
| 2025-03-25 07:35 |
Share Issue/Capital Change
臨時報告書
|
Japanese | 44.1 KB | |
| 2025-03-25 07:34 |
Registration Form
訂正有価証券届出書（参照方式）
|
Japanese | 312.0 KB | |
| 2025-03-25 07:32 |
Governance Information
内部統制報告書－第20期(2024/01/01－2024/12/31)
|
Japanese | 23.9 KB | |
| 2025-03-25 07:31 |
Registration Form
確認書
|
Japanese | 9.0 KB | |
| 2025-03-25 07:30 |
Annual Report
有価証券報告書－第20期(2024/01/01－2024/12/31)
|
Japanese | 1.9 MB | |
| 2025-02-20 08:20 |
Registration Form
訂正有価証券届出書（参照方式）
|
Japanese | 241.9 KB |
Automate Your Workflow. Get a real-time feed of all SymBio Pharmaceuticals Limited filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for SymBio Pharmaceuticals Limited via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
